inflammation

Four white arrows pointing to computer trash can icon

Biotech

Boehringer, Amgen scrap immunology assets, citing low potential

Phase 1 trials of BI's immune modulator and Amgen's ulcerative colitis small molecule have both been terminated.

Darren Incorvaia Apr 14, 2026 4:00am

road closed construction sign

Lipella goes bankrupt, ending mouth inflammation drug ambitions

Mar 31, 2026 7:20am

Half of brain next to half of heart

Rethinking heart attacks as the nervous system gone haywire

Jan 27, 2026 11:00am

Gilead Sciences Women HIV Movement campaign

JPM26: Gilead eyes new deals from a 'position of strength'

Jan 14, 2026 3:30am

Lilly buys inflammation biotech Ventyx for $1.2B

Jan 8, 2026 7:01am

MA gears up growth mergers buyout strategy

Tiziana to spin out IL-6 drug, cites pharma interest in modality

Dec 2, 2025 8:45am